Literature DB >> 26154448

The importance of distribution-choice in modeling substance use data: a comparison of negative binomial, beta binomial, and zero-inflated distributions.

Brandie Wagner1, Paula Riggs2, Susan Mikulich-Gilbertson1,2.   

Abstract

BACKGROUND: It is important to correctly understand the associations among addiction to multiple drugs and between co-occurring substance use and psychiatric disorders. Substance-specific outcomes (e.g. number of days used cannabis) have distributional characteristics which range widely depending on the substance and the sample being evaluated.
OBJECTIVES: We recommend a four-part strategy for determining the appropriate distribution for modeling substance use data. We demonstrate this strategy by comparing the model fit and resulting inferences from applying four different distributions to model use of substances that range greatly in the prevalence and frequency of their use.
METHODS: Using Timeline Followback (TLFB) data from a previously-published study, we used negative binomial, beta-binomial and their zero-inflated counterparts to model proportion of days during treatment of cannabis, cigarettes, alcohol, and opioid use. The fit for each distribution was evaluated with statistical model selection criteria, visual plots and a comparison of the resulting inferences.
RESULTS: We demonstrate the feasibility and utility of modeling each substance individually and show that no single distribution provides the best fit for all substances. Inferences regarding use of each substance and associations with important clinical variables were not consistent across models and differed by substance.
CONCLUSION: Thus, the distribution chosen for modeling substance use must be carefully selected and evaluated because it may impact the resulting conclusions. Furthermore, the common procedure of aggregating use across different substances may not be ideal.

Entities:  

Keywords:  Beta binomial; Timeline Followback; negative binomial; substance use; zero inflated

Mesh:

Year:  2015        PMID: 26154448      PMCID: PMC4692373          DOI: 10.3109/00952990.2015.1056447

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  17 in total

1.  Brief treatments for cannabis dependence: findings from a randomized multisite trial.

Authors: 
Journal:  J Consult Clin Psychol       Date:  2004-06

2.  Brief strategic family therapy versus treatment as usual: results of a multisite randomized trial for substance using adolescents.

Authors:  Michael S Robbins; Daniel J Feaster; Viviana E Horigian; Michael Rohrbaugh; Varda Shoham; Ken Bachrach; Michael Miller; Kathleen A Burlew; Candy Hodgkins; Ibis Carrion; Nancy Vandermark; Eric Schindler; Robert Werstlein; José Szapocznik
Journal:  J Consult Clin Psychol       Date:  2011-10-03

3.  The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials.

Authors:  Michael Dennis; Susan H Godley; Guy Diamond; Frank M Tims; Thomas Babor; Jean Donaldson; Howard Liddle; Janet C Titus; Yifrah Kaminer; Charles Webb; Nancy Hamilton; Rod Funk
Journal:  J Subst Abuse Treat       Date:  2004-10

4.  Advances in neurobiological research related to interventions in adolescents with substance use disorders: research to practice.

Authors:  Paula D Riggs; Laetitia L Thompson; Susan F Tapert; Joseph Frascella; Susan Mikulich-Gilbertson; Manish Dalwani; Mark Laudenslager; Michelle Lohman
Journal:  Drug Alcohol Depend       Date:  2007-12-01       Impact factor: 4.492

5.  Zero tolerance ecology: improving ecological inference by modelling the source of zero observations.

Authors:  Tara G Martin; Brendan A Wintle; Jonathan R Rhodes; Petra M Kuhnert; Scott A Field; Samantha J Low-Choy; Andrew J Tyre; Hugh P Possingham
Journal:  Ecol Lett       Date:  2005-11       Impact factor: 9.492

Review 6.  Measurement of drinking behavior using the Form 90 family of instruments.

Authors:  W R Miller; F K Del Boca
Journal:  J Stud Alcohol Suppl       Date:  1994-12

7.  Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders.

Authors:  Paula D Riggs; Theresa Winhusen; Robert D Davies; Jeffrey D Leimberger; Susan Mikulich-Gilbertson; Constance Klein; Marilyn Macdonald; Michelle Lohman; Genie L Bailey; Louise Haynes; William B Jaffee; Nancy Haminton; Candace Hodgkins; Elizabeth Whitmore; Kathlene Trello-Rishel; Leanne Tamm; Michelle C Acosta; Charlotte Royer-Malvestuto; Geetha Subramaniam; Marc Fishman; Beverly W Holmes; Mary Elyse Kaye; Mark A Vargo; George E Woody; Edward V Nunes; David Liu
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-08-04       Impact factor: 8.829

8.  Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder.

Authors:  Christian Thurstone; Paula D Riggs; Stacy Salomonsen-Sautel; Susan K Mikulich-Gilbertson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-06       Impact factor: 8.829

9.  A tutorial on count regression and zero-altered count models for longitudinal substance use data.

Authors:  David C Atkins; Scott A Baldwin; Cheng Zheng; Robert J Gallop; Clayton Neighbors
Journal:  Psychol Addict Behav       Date:  2012-08-20

10.  Impact of psychiatric comorbidity on treatment of adolescent drug abusers.

Authors:  Cynthia L Rowe; Howard A Liddle; Paul E Greenbaum; Craig E Henderson
Journal:  J Subst Abuse Treat       Date:  2004-03
View more
  15 in total

1.  Improving the analysis and modeling of substance use.

Authors:  David A Gorelick; Sterling McPherson
Journal:  Am J Drug Alcohol Abuse       Date:  2015-09-25       Impact factor: 3.829

2.  Prescribing Associated with High-Risk Opioid Exposures Among Non-cancer Chronic Users of Opioid Analgesics: a Social Network Analysis.

Authors:  Keiki Hinami; Michael J Ray; Kruti Doshi; Maria Torres; Steven Aks; John J Shannon; William E Trick
Journal:  J Gen Intern Med       Date:  2019-08-16       Impact factor: 5.128

3.  HealthCall delivered via smartphone to reduce co-occurring drug and alcohol use in HIV-infected adults: A randomized pilot trial.

Authors:  Efrat Aharonovich; Malka Stohl; Daniela Cannizzaro; Deborah Hasin
Journal:  J Subst Abuse Treat       Date:  2017-09-29

4.  Modeling count data in the addiction field: Some simple recommendations.

Authors:  Stéphanie Baggio; Katia Iglesias; Valentin Rousson
Journal:  Int J Methods Psychiatr Res       Date:  2017-10-13       Impact factor: 4.035

5.  Association of Reported Concern About Increasing Societal Discrimination With Adverse Behavioral Health Outcomes in Late Adolescence.

Authors:  Adam M Leventhal; Junhan Cho; Nafeesa Andrabi; Jessica Barrington-Trimis
Journal:  JAMA Pediatr       Date:  2018-10-01       Impact factor: 16.193

6.  MODELING MICROBIAL ABUNDANCES AND DYSBIOSIS WITH BETA-BINOMIAL REGRESSION.

Authors:  Bryan D Martin; Daniela Witten; Amy D Willis
Journal:  Ann Appl Stat       Date:  2020-04-16       Impact factor: 2.083

7.  Associations of Electronic Cigarette Nicotine Concentration With Subsequent Cigarette Smoking and Vaping Levels in Adolescents.

Authors:  Nicholas I Goldenson; Adam M Leventhal; Matthew D Stone; Rob S McConnell; Jessica L Barrington-Trimis
Journal:  JAMA Pediatr       Date:  2017-12-01       Impact factor: 16.193

8.  Models for analyzing zero-inflated and overdispersed count data: an application to cigarette and marijuana use.

Authors:  Brian Pittman; Eugenia Buta; Suchitra Krishnan-Sarin; Stephanie S O'Malley; Thomas Liss; Ralitza Gueorguieva
Journal:  Nicotine Tob Res       Date:  2018-04-18       Impact factor: 4.244

9.  Examining the differential effects of latent impulsivity factors on substance use outcomes in African American men.

Authors:  Lauren Bertin; Chelsie E Benca-Bachman; Steven M Kogan; Rohan H C Palmer
Journal:  Addict Behav       Date:  2021-01-26       Impact factor: 4.591

10.  Efficacy of an internet-based self-help intervention to reduce co-occurring alcohol misuse and depression symptoms in adults: study protocol of a three-arm randomised controlled trial.

Authors:  Michael P Schaub; Matthijs Blankers; Dirk Lehr; Leif Boss; Heleen Riper; Jack Dekker; Anna E Goudriaan; Larissa J Maier; Severin Haug; Manuel Amann; Michelle Dey; Andreas Wenger; David D Ebert
Journal:  BMJ Open       Date:  2016-05-25       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.